Skip to content
November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Breaking the Biological Barrier: Scientists Achieve Multi-Year Lifespan for Lab-Grown Brain Organoids breaking-the-biological-barrier-scientists-achieve-multi-year-lifespan-for-lab-grown-brain-organoids
  • Genomics and Precision Medicine

Breaking the Biological Barrier: Scientists Achieve Multi-Year Lifespan for Lab-Grown Brain Organoids

Evan Lee Salim August 21, 2026
In a landmark achievement for regenerative medicine and neurobiology, researchers from Harvard University and the Broad Institute...
Read More Read more about Breaking the Biological Barrier: Scientists Achieve Multi-Year Lifespan for Lab-Grown Brain Organoids
Shaping the Future of Medicine: ASHG Announces 2026 Professional Award Recipients shaping-the-future-of-medicine-ashg-announces-2026-professional-award-recipients
  • Genomics and Precision Medicine

Shaping the Future of Medicine: ASHG Announces 2026 Professional Award Recipients

Layla Zulfa August 21, 2026
ROCKVILLE, Md. — The American Society of Human Genetics (ASHG), the world’s preeminent professional membership organization for...
Read More Read more about Shaping the Future of Medicine: ASHG Announces 2026 Professional Award Recipients
Beyond the Finish Line: A New Framework for Post-Cancer Restoration beyond-the-finish-line-a-new-framework-for-post-cancer-restoration
  • Survivorship and Post-Treatment

Beyond the Finish Line: A New Framework for Post-Cancer Restoration

Lina Hope August 21, 2026
This article features insights from breast cancer survivor and patient advocate Jessica Baladad. The following content is...
Read More Read more about Beyond the Finish Line: A New Framework for Post-Cancer Restoration
Novo Nordisk Explores Lower Doses of Oral Wegovy in Landmark OASIS-5 Trial Amidst Intensifying Market Competition novo-nordisk-explores-lower-doses-of-oral-wegovy-in-landmark-oasis-5-trial-amidst-intensifying-market-competition
  • Medical Research and Clinical Trials

Novo Nordisk Explores Lower Doses of Oral Wegovy in Landmark OASIS-5 Trial Amidst Intensifying Market Competition

Nana Wu August 21, 2026
Copenhagen, Denmark & Boston, USA – August 22, 2026 – In a significant move within the rapidly...
Read More Read more about Novo Nordisk Explores Lower Doses of Oral Wegovy in Landmark OASIS-5 Trial Amidst Intensifying Market Competition
Ultragenyx Secures Strategic Win with FDA Approval of Genglycos ultragenyx-secures-strategic-win-with-fda-approval-of-genglycos
  • Treatment Innovations

Ultragenyx Secures Strategic Win with FDA Approval of Genglycos

Lina Hope August 21, 2026
The landscape for rare disease treatment saw a significant shift on August 19, 2026, as the U.S....
Read More Read more about Ultragenyx Secures Strategic Win with FDA Approval of Genglycos
The Silent Crisis: Navigating the Complex Psychosocial Landscape of AYA Cancer Survivorship the-silent-crisis-navigating-the-complex-psychosocial-landscape-of-aya-cancer-survivorship
  • Clinical Oncology Education

The Silent Crisis: Navigating the Complex Psychosocial Landscape of AYA Cancer Survivorship

Nana Muazin August 21, 2026
The diagnosis of cancer is a life-altering event for any individual, but for adolescents and young adults...
Read More Read more about The Silent Crisis: Navigating the Complex Psychosocial Landscape of AYA Cancer Survivorship
Every Day is Christmas: The Remarkable Second Act of Steve O’Grady every-day-is-christmas-the-remarkable-second-act-of-steve-ogrady
  • Survivorship and Post-Treatment

Every Day is Christmas: The Remarkable Second Act of Steve O’Grady

Asro August 21, 2026
By [Your Name/Editorial Staff] For Steve O’Grady, a U.S. Navy veteran and lifelong farm boy, the concept...
Read More Read more about Every Day is Christmas: The Remarkable Second Act of Steve O’Grady
The Stability Imperative: Engineering the Future of Multifunctional Peptide Therapeutics the-stability-imperative-engineering-the-future-of-multifunctional-peptide-therapeutics
  • Chemotherapy and Targeted Therapy

The Stability Imperative: Engineering the Future of Multifunctional Peptide Therapeutics

Nana Wu August 21, 2026
The landscape of modern pharmacology is undergoing a tectonic shift. While small-molecule drugs have dominated the pharmaceutical...
Read More Read more about The Stability Imperative: Engineering the Future of Multifunctional Peptide Therapeutics
A New Dawn: Moderna’s Cancer Vaccine Breakthrough Sparks $45 Billion Market Rally a-new-dawn-modernas-cancer-vaccine-breakthrough-sparks-45-billion-market-rally
  • Chemotherapy and Targeted Therapy

A New Dawn: Moderna’s Cancer Vaccine Breakthrough Sparks $45 Billion Market Rally

Layla Zulfa August 20, 2026
Main Facts: The Turning Point After a punishing multiyear slide that saw its share price plummet from...
Read More Read more about A New Dawn: Moderna’s Cancer Vaccine Breakthrough Sparks $45 Billion Market Rally
The Transparency Shift: Analyzing the First Year of Mandatory Prior Authorization Data the-transparency-shift-analyzing-the-first-year-of-mandatory-prior-authorization-data
  • Breast Cancer Legislation and Policy

The Transparency Shift: Analyzing the First Year of Mandatory Prior Authorization Data

Reynand Wu August 20, 2026
The U.S. healthcare system has long operated under a veil of ambiguity regarding the “prior authorization” process—a...
Read More Read more about The Transparency Shift: Analyzing the First Year of Mandatory Prior Authorization Data

Posts pagination

Previous 1 … 377 378 379 380 381 382 383 … 851 Next

Recent Posts

  • Landmark UK Approval Paves Way for First Disease-Modifying Therapy for Rare Mitochondrial Disorder
  • Beyond Philanthropy: Forging Powerful Corporate-Nonprofit Partnerships for Mutual Growth and Impact
  • The Evolution of Advocacy: Dr. Kelly Shanahan and the Changing Landscape of Metastatic Breast Cancer Research
  • Harnessing Intelligence: BCRF Symposium to Showcase AI-Driven Revolution in Breast Cancer Research
  • Dexcom Signals Sustained Growth: Financial Outlook Raised Following Strong Q3 Performance

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

landmark-uk-approval-paves-way-for-first-disease-modifying-therapy-for-rare-mitochondrial-disorder
  • Medical Research and Clinical Trials

Landmark UK Approval Paves Way for First Disease-Modifying Therapy for Rare Mitochondrial Disorder

Asep Darmawan November 2, 2026
beyond-philanthropy-forging-powerful-corporate-nonprofit-partnerships-for-mutual-growth-and-impact
  • Patient Advocacy and Support

Beyond Philanthropy: Forging Powerful Corporate-Nonprofit Partnerships for Mutual Growth and Impact

Laily UPN November 2, 2026
the-evolution-of-advocacy-dr-kelly-shanahan-and-the-changing-landscape-of-metastatic-breast-cancer-research
  • Patient Advocacy and Support

The Evolution of Advocacy: Dr. Kelly Shanahan and the Changing Landscape of Metastatic Breast Cancer Research

Nana Wu November 2, 2026
harnessing-intelligence-bcrf-symposium-to-showcase-ai-driven-revolution-in-breast-cancer-research
  • Patient Advocacy and Support

Harnessing Intelligence: BCRF Symposium to Showcase AI-Driven Revolution in Breast Cancer Research

Ali Ikhwan November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.